| Samantha Koehn, LCSW | |
|
321 N Mall Dr Ste F202, Saint George, UT 84790-7351 | |
| (435) 414-1114 | |
| Not Available |
| Full Name | Samantha Koehn |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 321 N Mall Dr Ste F202, Saint George, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194271957 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 10378645-3501 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Koehn, LCSW 1380 E Medical Center Dr, St George, UT 84790-2123 Ph: (435) 251-2431 | Samantha Koehn, LCSW 321 N Mall Dr Ste F202, Saint George, UT 84790-7351 Ph: (435) 414-1114 |
News Archive
The University of North Carolina at Chapel Hill is one of twelve centers announced today by President Obama as part of an unprecedented large-scale, collaborative effort by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
New research from Lucile Packard Children's Hospital and the Stanford University School of Medicine is helping physicians unravel the cause of a deadly and mysterious bowel disease that strikes medically fragile newborn babies.
In the United States, massive volumes of individual-level data, called "big data," are used for a variety of reasons, including marketing, intelligence gathering and political campaigns.
Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study appearing in JAMA.
› Verified 2 days ago
Kimi L Endter, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 437 S Bluff St Ste 302, Saint George, UT 84770 Phone: 435-634-8848 | |
Henry Lawson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 348 E 600 S, Saint George, UT 84770 Phone: 435-705-7574 | |
Tanya Farr, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 321 N Mall Dr Ste 105, Saint George, UT 84790 Phone: 435-673-1108 | |
Ari Mendez, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 25 N 100 E, Ste 102, Saint George, UT 84770 Phone: 435-986-2565 Fax: 435-986-8700 | |
Megan Chepkwurui, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2801 E 450 N Apt 50, Saint George, UT 84790 Phone: 435-632-3023 | |
Craig L Skousen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1630 E 2450 S Unit 121, Saint George, UT 84790 Phone: 435-668-4983 |